Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Biomolecules|May 28, 2025
Sex Differences in Brain Transcriptomes of Juvenile Cynomolgus MacaquesNadia Kabbej, Frederick J Ashby, Alberto Riva, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2004
Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous systemCorinna Burger, Oleg S Gorbatyuk, Margaret J Velardo, et al.
Journal of Neuroscience Methods|May 18, 2006
A method for a more complete in vitro Parkinson's model: slice culture bioassay for modeling maintenance and repair of the nigrostriatal circuitSean M Kearns, Bjorn Scheffler, A Katrin Goetz, et al.
Experimental Neurology|November 26, 2003
Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus)Andisheh Eslamboli, Rosalyn M Cummings, Rosalind M Ridley, et al.
Gene Therapy|November 27, 2020
Site-specific modifications to AAV8 capsid yields enhanced brain transduction in the neonatal MPS IIIB mouseJanine A Gilkes, Benjamin L Judkins, Brontie N Herrera, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 6, 2009
Positron emission tomography imaging demonstrates correlation between behavioral recovery and correction of dopamine neurotransmission after gene therapyLudovic Leriche, Tomas Björklund, Nathalie Breysse, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 29, 2010
α-Synuclein expression in rat substantia nigra suppresses phospholipase D2 toxicity and nigral neurodegenerationOleg S Gorbatyuk, Shoudong Li, Frederic Nha Nguyen, et al.
Neurobiology of Aging|June 21, 2005
Hypothalamic rAAV-mediated GDNF gene delivery ameliorates age-related obesityNihal Tümer, Philip J Scarpace, M Devrim Dogan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2009
Tight Long-term dynamic doxycycline responsive nigrostriatal GDNF using a single rAAV vectorFredric P Manfredsson, Corinna Burger, Aaron C Rising, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2010
In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degenerationOleg S Gorbatyuk, Shoudong Li, Kevin Nash, et al.
Pageof 6